A test being developed by Clarient could predict which ovarian cancer patients will respond to taxane chemotherapy drugs, a study has found. Taxanes, which include paclitaxel and docetaxel, are commonly used to treat ovarian and other cancers. Studies have found that adding a taxane to ...
Please Login to read the full article.
